GlassScriptPhysician profile
James Harrison Beattie
NPI 1487655189
$1,883.59
in general payments reported to CMS, 2019-2025
20 companies · $314 in 2025
The $314 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $145 · 2021: $436 · 2022: $296 · 2023: $174 · 2024: $297 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $277.86 | 2021-2025 | Azstarys, Azstarys |
| Pfizer INC. | $226.29 | 2019-2025 | |
| Sanofi Pasteur INC. | $194.83 | 2019-2025 | |
| Glaxosmithkline, LLC. | $194.50 | 2019-2025 | Bexsero, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $159.17 | 2019-2022 | |
| Seqirus USA INC | $126.05 | 2023-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Merck Sharp & Dohme LLC | $119.36 | 2021-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Supernus Pharmaceuticals, INC. | $104.14 | 2021-2022 | |
| Cranial Technologies, INC | $103.20 | 2019-2024 | Doc Band |
| Tris Pharma INC | $89.50 | 2020-2025 | Quillivant |
| Sanofi-Aventis U.S. LLC | $48.06 | 2024-2025 | |
| Adlon Therapeutics L.P. | $43.30 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $39.68 | 2019-2024 | |
| Genentech USA, INC. | $36.17 | 2019-2021 | |
| Neurelis, INC. | $28.99 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $20.16 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $19.89 | 2025 | Jornay Pm |
| Mylan Pharmaceuticals INC. | $18.94 | 2019 | |
| Kaleo, INC. | $17.45 | 2021 | |
| Rhodes Pharmaceuticals L.P. | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Beattie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.